by Dr. Joseph Mercola, Mercola: STORY AT-A-GLANCE ViAqua Therapeutics, an Israeli-based biotechnology startup, has secured $8.25 million in funding for its oral RNA-based shrimp vaccine The vaccine targets white spot syndrome virus (WSSV), which leads to a 15% reduction in global shrimp production each year ViAqua plans to administer its RNA-based product via coated feed; […]
Source